The Pattern of Failure After Reirradiation of Recurrent Squamous Cell Head and Neck Cancer: Implications for Defining the Targets

International Journal of Radiation Oncology Biology Physics

Volumn 74, Issue 5, 2009, Pages 1342-1347

  Popovtzer, Aron ^a   Gluck, Iris ^a   Chepeha, Douglas B ^a   Teknos, Theodoros N ^a   Moyer, Jeffrey S ^a   Prince, Mark E ^a   Bradford, Carol R ^a   Eisbruch, Avraham ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

3D radiotherapy; IMRT; Recurrent head and neck cancer; Reirradiation; Target definition

Indexed keywords

3D RADIOTHERAPY; CONFIDENCE INTERVAL; GROSS TUMOR VOLUME; HEAD-AND-NECK CANCER; HIGH RATE; IMRT; LYMPH NODE; PERSISTENT DISEASE; RECURRENT HEAD AND NECK CANCER; REIRRADIATION;

CELL MEMBRANES; CHEMOTHERAPY; DISEASE CONTROL; PHYSICAL THERAPY; RADIOTHERAPY; TARGETS; TUMORS;

THREE DIMENSIONAL;

CARBOPLATIN; CETUXIMAB; CISPLATIN; DOCETAXEL; FLUOROURACIL;

ADOLESCENT; ADULT; AGED; ARTICLE; BRAIN NECROSIS; CANCER COMBINATION CHEMOTHERAPY; CANCER RECURRENCE; COMPUTER ASSISTED RADIOTHERAPY; CONTROLLED STUDY; DYSPHAGIA; FEMALE; HEAD AND NECK CANCER; HUMAN; INTENSITY MODULATED RADIATION THERAPY; KIDNEY FAILURE; LARYNGEAL CHRONDONECROSIS; LARYNGECTOMY; LARYNX DISORDER; LARYNX EDEMA; MAJOR CLINICAL STUDY; MALE; PHARYNX DISEASE; PHARYNX STENOSIS; PRIORITY JOURNAL; RADIATION DOSE; SQUAMOUS CELL CARCINOMA; TREATMENT FAILURE; TUMOR VOLUME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CONFIDENCE INTERVALS; FEMALE; FOLLOW-UP STUDIES; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; MUCOUS MEMBRANE; NEOPLASM RECURRENCE, LOCAL; PROPORTIONAL HAZARDS MODELS; RADIOTHERAPY DOSAGE; RADIOTHERAPY, CONFORMAL; RETREATMENT; RETROSPECTIVE STUDIES; TREATMENT FAILURE; TUMOR BURDEN; YOUNG ADULT;

EID: 67651093867     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2008.10.042     Document Type: Article

References (29)

1. Cooper J.S., Pajak T.F., Forastiere A.A., et al. Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N Engl J Med 350 (2004) 1937-1944
2. Bernier J., Domenge C., Ozsahin M., et al. Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med 350 (2004) 1945-1952
3. Forastiere A.A., Goepfert H., Maor M., et al. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med 349 (2003) 2091-2098
4. Forastiere A., Koch W., Trotti A., et al. Head and neck cancer. N Engl J Med 345 (2001) 1890-1900
5. Wong L.Y., Wei W.I., Lam L.K., et al. Salvage of recurrent head and neck squamous cell carcinoma after primary curative surgery. Head Neck 25 (2003) 953-959
6. Parsons J.T., Mendenhall W.M., Stringer S.P., et al. Salvage surgery following radiation failure in squamous cell carcinoma of the supraglottic larynx. Int J Radiat Oncol Biol Phys 32 (1995) 605-609
7. Mabanta S.R., Mendenhall W.M., Stringer S.P., et al. Salvage treatment for neck recurrence after irradiation alone for head and neck squamous cell carcinoma with clinically positive neck nodes. Head Neck 21 (1999) 591-594
8. McLaughlin M.P., Parsons J.T., Fein D.A., et al. Salvage surgery after radiotherapy failure in T1-T2 squamous cell carcinoma Of the glottic larynx. Head Neck 18 (1996) 229-235
9. Forastiere A.A., Metch B., Schuller D.E., et al. Randomized comparison of cisplatin plus fluorouracil and carboplatin plus fluorouracil versus methotrexate in advanced squamous-cell carcinoma of the head and neck: A Southwest Oncology Group study. J Clin Oncol 10 (1992) 1245-1251
10. Hehr T., Classen J., Belka C., et al. Reirradiation alternating with docetaxel and cisplatin in inoperable recurrence of head-and-neck cancer: A prospective Phase I/II trial. Int J Radiat Oncol Biol Phys 61 (2005) 1423-1431
11. Kasperts N., Slotman B.J., Leemans C.R., et al. Results of postoperative reirradiation for recurrent or second primary head and neck carcinoma. Cancer 106 (2006) 1536-1547
12. Lee N., Chan K., Bekelman J.E., et al. Salvage re-irradiation for recurrent head and neck cancer. Int J Radiat Oncol Biol Phys 68 (2007) 731-740
13. Biagioli M.C., Harvey M., Roman E., et al. Modulated radiotherapy with concurrent chemotherapy for previously irradiated, recurrent head and neck cancer. Int J Radiat Oncol Biol Phys 69 (2007) 1067-1073
14. Sulman EP, Schwartz DL, Le TT, et al. IMRT reirradiation of head and neck cancer-disease control and morbidity outcomes [Epub ahead of print, June 13]. Int J Radiat Oncol Biol Phys.
15. Salama J.K., Vokes E.E., Chmura S.J., et al. Long-term outcome of concurrent chemotherapy and reirradiation for recurrent and second primary head-and-neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys 64 (2006) 382-391
16. De C., Bourhis J., Domenge C., et al. Full-dose reirradiation for unresectable head and neck carcinoma: Experience at the Gustave-Roussy Institute in a series of 169 patients. J Clin Oncol 16 (1998) 3556-3562
17. Spencer S.A., Harris J., Wheeler R.H., et al. Final report of RTOG 9610, a multi-institutional trial of reirradiation and chemotherapy for unresectable recurrent squamous cell carcinoma of the head and neck. Head Neck 30 (2008) 281-288
18. Langer C.J., Harris J., Horwitz E.M., et al. Phase II study of low-dose paclitaxel and cisplatin in combination with split-course concomitant twice-daily reirradiation in recurrent squamous cell carcinoma of the head and neck: Results of Radiation Therapy Oncology Group Protocol 9911. J Clin Oncol 25 (2007) 4800-4805
19. Schaefer U., Micke O., Schueller P., and Willich N. Recurrent head and neck cancer: Retreatment of previously irradiated areas with combined chemotherapy and radiation therapy-results of a prospective study. Radiology 216 (2000) 371-378
20. Goldstein D.P., Karnell L.H., Yao M., et al. Outcomes following reirradiation of patients with head and neck cancer. Head Neck 30 (2008) 765-770
21. Kramer N.M., Horwitz E.M., Cheng J., et al. Toxicity and outcome analysis of patients with recurrent head and neck cancer treated with hyperfractionated split-course reirradiation and concurrent cisplatin and paclitaxel. Head Neck 27 (2005) 406-414
22. Dawson L.A., Myers L.L., Bradford C.R., et al. Conformal re-irradiation of recurrent and new primary head-and-neck cancer. Int J Radiat Oncol Biol Phys 50 (2001) 377-385
23. Fraass B.A., Kessler M.A., McShan D.L., et al. Optimization and clinical use of multisegment intensity-modulated radiation therapy for high-dose conformal therapy. Semin Radiat Oncol 9 (1999) 60-77
24. Vineberg K.A., Eisbruch A., Coselmon M.M., et al. Is uniform target dose possible in IMRT plans in the head and neck. Int J Radiat Oncol Biol Phys 52 (2002) 1159-1172
25. Brizel D.M., Albers M.E., Fisher S.R., et al. Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer. N Engl J Med 338 (1998) 1798-1804
26. Allen A.M., Elshaikh M., Worden F.P., et al. Acceleration of hyperfractionated chemoradiation regimen for advanced head and neck cancer. Head Neck 29 (2007) 137-142
27. Dawson L.A., Anzai Y., Marsh L., et al. Patterns of local-regional recurrence following parotid-sparing conformal and segmental intensity-modulated radiotherapy for head and neck cancer. Int J Radiat Oncol Biol Phys 46 (2000) 1117-1126
28. Khafif R.A., Gelbfish G.A., Attie J.N., et al. Thirty-year experience with 457 radical neck dissections in cancer of the mouth, pharynx, and larynx. Am J Surg 158 (1989) 303-307
29. Fisch U. Cervical lymph flow following surgery in the neck. In: Fisch U. (Ed). Lymphography of the cervical lymphatic system (1968), WB Saunders, Philadelphia 112-141